SAREPTA THERAPEUTICS INC
NASDAQ: SRPT (Sarepta Therapeutics, Inc.)
Kemas kini terakhir: 19 jam lalu22.26
-0.56 (-2.45%)
| Penutupan Terdahulu | 22.82 |
| Buka | 22.84 |
| Jumlah Dagangan | 2,619,981 |
| Purata Dagangan (3B) | 5,527,571 |
| Modal Pasaran | 2,332,562,688 |
| Harga / Pendapatan (P/E Ke hadapan) | 17.61 |
| Harga / Jualan (P/S) | 1.00 |
| Harga / Buku (P/B) | 1.73 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 3 Nov 2025 |
| Margin Keuntungan | -11.12% |
| Margin Operasi (TTM) | -40.33% |
| EPS Cair (TTM) | -2.64 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 80.20% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | 248.40% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 118.73% |
| Nisbah Semasa (MRQ) | 4.02 |
| Aliran Tunai Operasi (OCF TTM) | -547.15 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -741.26 M |
| Pulangan Atas Aset (ROA TTM) | -2.19% |
| Pulangan Atas Ekuiti (ROE TTM) | -23.61% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Menaik | Bercampur |
| Biotechnology (Global) | Menaik | Bercampur | |
| Stok | Sarepta Therapeutics, Inc. | Bercampur | Menurun |
AISkor Stockmoo
| Konsensus Penganalisis | -1.5 |
| Aktiviti Orang Dalam | -3.0 |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 3.5 |
| Osilator Teknikal | 2.0 |
| Purata | -0.20 |
|
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 4.42% |
| % Dimiliki oleh Institusi | 96.33% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 50.00 (BMO Capital, 124.62%) | Beli |
| Median | 19.50 (-12.40%) | |
| Rendah | 15.00 (Baird, -32.62%) | Pegang |
| 15.00 (Leerink Partners, -32.62%) | Pegang | |
| Purata | 25.75 (15.68%) | |
| Jumlah | 4 Beli, 4 Pegang | |
| Harga Purata @ Panggilan | 18.80 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Barclays | 05 Nov 2025 | 20.00 (-10.15%) | Pegang | 18.67 |
| Guggenheim | 05 Nov 2025 | 19.00 (-14.65%) | Beli | 18.67 |
| 15 Sep 2025 | 22.00 (-1.17%) | Beli | 17.47 | |
| Mizuho | 05 Nov 2025 | 26.00 (16.80%) | Beli | 18.67 |
| Wells Fargo | 05 Nov 2025 | 45.00 (102.16%) | Beli | 18.67 |
| Baird | 04 Nov 2025 | 15.00 (-32.61%) | Pegang | 16.20 |
| Piper Sandler | 30 Oct 2025 | 16.00 (-28.12%) | Pegang | 23.25 |
| BMO Capital | 22 Sep 2025 | 50.00 (124.62%) | Beli | 18.65 |
| Leerink Partners | 09 Sep 2025 | 15.00 (-32.61%) | Pegang | 17.64 |
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| ROTHFUSS CRISTIN | - | 21.34 | -229 | -4,887 |
| Jumlah Keseluruhan Kuantiti Bersih | -229 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | -4,887 | |||
| Purata Pembelian Keseluruhan ($) | - | |||
| Purata Jualan Keseluruhan ($) | 21.34 | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| ROTHFUSS CRISTIN | Pegawai | 28 Nov 2025 | Dibuang (-) | 229 | 21.34 | 4,887 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |